Jess S. Morgan & Co’s Rein Therapeutics, Inc. Common Stock RNTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-5,000
| Closed | -$51K | – | 47 |
|
2022
Q1 | $51K | Hold |
5,000
| – | – | 0.04% | 42 |
|
2021
Q4 | $56K | Buy |
5,000
+1,250
| +33% | +$14K | 0.03% | 44 |
|
2021
Q3 | $76K | Hold |
3,750
| – | – | 0.05% | 40 |
|
2021
Q2 | $94K | Buy |
3,750
+500
| +15% | +$12.5K | 0.06% | 40 |
|
2021
Q1 | $93K | Hold |
3,250
| – | – | 0.07% | 44 |
|
2020
Q4 | $68K | Sell |
3,250
-250
| -7% | -$5.23K | 0.05% | 40 |
|
2020
Q3 | $90K | Hold |
3,500
| – | – | 0.09% | 39 |
|
2020
Q2 | $83K | Sell |
3,500
-1,500
| -30% | -$35.6K | 0.09% | 38 |
|
2020
Q1 | $33K | Sell |
5,000
-1,250
| -20% | -$8.25K | 0.04% | 38 |
|
2019
Q4 | $72K | Buy |
+6,250
| New | +$72K | 0.07% | 40 |
|